New study aims to spare breast cancer patients from extensive surgery

NCT ID NCT05763641

Recruiting now Knowledge-focused Sponsor: Hospital Universitari de Bellvitge Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is testing whether a less invasive procedure called target axillary dissection (TAD) can accurately check for cancer spread in the lymph nodes of people with locally advanced breast cancer after chemotherapy. The goal is to see if TAD can replace more extensive lymph node removal, which often causes long-term side effects like arm swelling. The study will enroll 162 participants and compare TAD results with standard full lymph node removal.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could validate a less invasive surgical approach for advanced breast cancer, potentially reducing arm swelling and other complications.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly improve outcomes. The method may not be accurate enough to replace standard surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER LOCALLY ADVANCED SENTINEL LYMPH NODE

Contacts and locations

Locations

Hospital Clínico y Provincial de Barcelona
RECRUITING

Barcelona, 08036, Spain
Hospital de Bellvitge
RECRUITING

L'Hospitalet de Llobregat, Barcelona, 08907, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.